| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |